doctitl nation eye institut nation institut arthriti musculoskelet skin diseas nation institut child health human develop licens opportun opportun cooper research develop agreement crada use antiflammin doctitl agenc agenc nation institut health public health servic dhh agenc action action notic action summari summari nation institut health seek license crada partner develop commerci patent portfolio antiflammin invent claim follow patent applic avail either exclus non exclus licens accord 35 u c 207 37 cfr part 404 develop one crada sever clinic import applic describ supplementari inform anti inflammatori agent mukherje b nichd file 19 nov 1987 serial 07 122 379 u patent 5 266 562 issu 30 nov 1993 method treat ocular inflammatori diseas use antiflammin chan c c nei file 7 jun 1993 serial 08 073 380 speed research develop commerci new class drug nation institut health seek one licens agreement crada pharmaceut biotechnolog compani accord regul govern transfer govern develop agent propos use antiflammin treatment inflammatori diseas process consid summari address address crada propos question opportun address ms karen wright offic technolog develop nation eye institut build 10 room 10n202 bethesda md 20892 301 4969463 crada propos must receiv date specifi licens propos question opportun address ms carol lavrich offic technolog transfer nation institut health 6011 execut boulevard rockvil md 20852 301 4967735 ext 287 inform patent patent applic pertin inform yet publicli describ obtain confidenti disclosur agreement responde interest licens invent requir submit applic licens public health servic invent responde interest submit crada propos awar may necessari secur licens patent right order commerci product aris crada agreement address date date deadlin licens applic must receiv crada propos must receiv novemb 14 1994 date supplem supplementari inform antiflammin biolog activ synthet oligopeptid deriv sequenc similar lipo cortin 1 uteroglobin anti inflammatori protein peptid antiphospholipas 2 immunomodulatori properti great therapeut potenti specif potent antiflammin drug may develop scientist sever institut nation institut health examin use antiflammin treatment varieti inflammatori process includ acut anterior ocular inflamm uveiti psoriasi neonat respiratori distress syndrom rd bronchopulmonari dysplasia bpd dr chi cho chan dr scott whitcup clinic investig nation eye institut nei ind use antiflammin 2 acut anterior uveiti seven patient alreadi enrol clinic trial date toxic observ patient treat drug nei interest develop new topic formul antiflammin initi multi center random clinic trial antiflammin treatment anterior uveiti post oper ocular inflamm allerg conjunct dr john digiovanna investig nation institut arthriti musculoskelet skin diseas niam studi use antiflammin treat psoriasi hyperprolif inflammatori skin diseas dr digiovanna would like continu expand studi includ inflammatori skin diseas atop contact dermat well develop anim vitro model studi effect antiflammin skin supplem